(Q50532452)

14 March 2018

title

Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells. (English)

1 reference

14 March 2018

0 references

1 reference

1 reference

T Takahashi

1

1 reference

14 March 2018

W Maruyama

2

1 reference

14 March 2018

Y Deng

3

1 reference

14 March 2018

P Dostert

4

1 reference

14 March 2018

D Nakahara

5

1 reference

14 March 2018

T Niwa

6

1 reference

14 March 2018

S Ohta

7

1 reference

14 March 2018

M Naoi

8

1 reference

14 March 2018

publication date

1 January 1997

1 reference

14 March 2018

Journal of Neural Transmission

published in

1 reference

14 March 2018

volume

104

1 reference

14 March 2018

issue

1

1 reference

14 March 2018

page(s)

59-66

1 reference

14 March 2018

https://scigraph.springernature.com/pub.10.1007/bf01271294

exact match

0 references

cites work

A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol.

1 reference

12 December 2020

Enzymatic oxidation of the dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion

1 reference

12 December 2020

Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans

1 reference

12 December 2020

Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies

1 reference

12 December 2020

1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.

1 reference

12 December 2020

N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.

1 reference

12 December 2020

Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans.

1 reference

12 December 2020

Alkaloids in mammalian tissues. 2. Synthesis of (+)- and (-)-1-substituted-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines

1 reference

12 December 2020

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

12 December 2020

A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian cerebrospinal fluid

1 reference

12 December 2020

Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain

1 reference

12 December 2020

A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay

1 reference

12 December 2020

Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)

1 reference

12 December 2020

Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.

1 reference

12 December 2020

A new fluorometric assay for cytotoxicity measurements in-vitro.

1 reference

12 December 2020

Determination of the (R)- and (S)-enantiomers of salsolinol and N-methylsalsolinol by use of a chiral high-performance liquid chromatographic column

1 reference

12 December 2020

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.

1 reference

12 December 2020

Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains

1 reference

12 December 2020

Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatography—tandem mass spectrometry

1 reference

12 December 2020

N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.

1 reference

12 December 2020

N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity

1 reference

12 December 2020

Salsolinol and catecholamines in human brain and their relation to alcoholism.

1 reference

12 December 2020

Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates

1 reference

12 December 2020

Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system

1 reference

12 December 2020

Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines

1 reference

12 December 2020

The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells.

1 reference

12 December 2020

Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.

1 reference

12 December 2020

Ratio of the R and S enantiomers of salsolinol in food and human urine

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01271294

1 reference

14 March 2018

PubMed ID

9085193

1 reference

14 March 2018